Why Siemens Broke Up Its 150-Year Industrial Empire — Complete Analysis of the Healthineers & Energy Spinoffs
Eliminating the conglomerate discount · Carve-out IPO + tax-free spinoff · Transforming a German industrial giant into pure-play leaders
Background
Siemens AG was founded in Berlin in 1847 by Werner von Siemens, initially building telegraph systems. Over 150+ years it expanded into power generation, medical imaging, industrial automation, rail transportation, and wind energy — one of the most diversified industrial conglomerates in the world. By the early 2010s, Siemens operated across energy (gas turbines, power grids), healthcare (MRI, CT, diagnostics), industrial automation (PLCs, software), transportation (rail signals, trains), and wind power (Siemens Gamesa) — all under one legal entity.
When Joe Kaeser became CEO in 2014, he launched Vision 2020 and later Vision 2020+ — a multi-year strategic transformation to spin out unrelated businesses and concentrate Siemens AG on digital industrial automation (Industry 4.0). The core insight was that medical devices (high-growth, high-margin), energy (low-growth, cyclical), and industrial automation (moderate-growth, digital premium) deserved entirely different valuation multiples — but as a single conglomerate, they were all priced at a blended average that undervalued each.
In March 2018, Siemens Healthineers listed on the Frankfurt Stock Exchange via a carve-out IPO. The offering raised €4.2B and valued the company at €31B on listing day. Siemens AG retained 85% of the shares. The listing gave medical device investors direct access to the world's leading MRI, CT, and diagnostic imaging platform — and immediately unlocked a 25x+ EV/EBITDA medical device multiple that had been buried inside the conglomerate.
In September 2020, Siemens Energy AG — comprising gas turbines, power transmission, and a 67% stake in Siemens Gamesa Renewable Energy — was spun off and listed on the Frankfurt Stock Exchange. Siemens AG shareholders received a direct 35% allocation, and Siemens Energy was included in the DAX 30 index. Siemens AG was now a focused digital-industrial company: Digital Industries (automation software), Smart Infrastructure (building management), and Mobility (rail signaling and trains).
Deal Summary
- Deal Value
- Healthineers market cap €33B+ (carve-out IPO) + Siemens Energy spinoff
- Acquirer
- Siemens AG (restructuring entity)
- Target
- Siemens Healthineers + Siemens Energy AG
- Announced
- Mar 2018 (Healthineers IPO)
- Closed
- Sep 2020 (Energy spinoff completed)
- Country
- Germany
Executive Summary
- 150-year German industrial conglomerate Siemens executes Vision 2020+ — spinning out unrelated businesses for pure-play focus
- Mar 2018: Siemens Healthineers Frankfurt carve-out IPO; €4.2B raised; €31B initial market cap
- Sep 2020: Siemens Energy AG (gas turbines + power grids + Gamesa wind) listed on Frankfurt; DAX 30 inclusion
- Siemens AG retained: Digital Industries (automation) + Smart Infrastructure + Mobility (rail) — pure-play digital-industrial
- Siemens Healthineers: Post-spinoff acquired Varian Medical for $16B; market cap €33B+ (2023) — success case
- Siemens Energy: Gamesa wind turbine defects caused billions in losses; stock -50%+ — risk case
- Siemens AG market cap €100B+ (2024), +80% vs. pre-breakup — conglomerate discount successfully eliminated
Industry Overview
In the 2010s, global industrial conglomerates faced twin pressures. First, activist investors demanded breakups, citing conglomerate discounts that suppressed valuations below the sum-of-parts. Second, the Fourth Industrial Revolution (Industry 4.0) made industrial automation and digitalization the highest-multiple segment — but only when isolated from lower-multiple businesses in clean pure-play form. GE (U.S.) and ABB (Switzerland) underwent similar separations. Medical devices became a high-growth, high-margin sector driven by population aging, while energy faced the structural disruption of renewable transition.
Global Medical Device Market
~€400B
2020; growing 5%+ annually
Global Energy Transition Investment
$500B+
2020; renewables + grid
Siemens AG Market Cap (pre-breakup)
~€56B
2018 baseline
Siemens AG Market Cap (2024)
€100B+
+80% vs. pre-breakup
German industrial restructuring carries unique institutional constraints compared to U.S. equivalents. Germany's Mitbestimmung (co-determination) system places worker representatives on half of supervisory board seats. Large-scale spinoffs require upfront negotiation with unions — particularly IG Metall — on employment guarantees. This slows restructuring timelines but tends to improve outcomes for the workforce. Siemens's national strategic importance also meant that politically sensitive asset sales to foreign buyers would have generated significant opposition.
Key Players
Company Overview: Siemens AG (pre-separation) — Healthineers + Energy included
Founded in 1847, Siemens grew from telegraph equipment to become one of the world's largest and most diversified industrial companies. At its most expansive, Siemens manufactured everything from household appliances to nuclear power plant components, jet engine parts, medical imaging systems, rail signaling, and semiconductor manufacturing equipment. By the 2010s, Siemens had narrowed its focus to energy, healthcare, industrial automation, transportation, and wind — but the remaining combination still carried significant conglomerate discount relative to specialized peers.
Founded
1847
Werner von Siemens; telegraph systems
Employees (pre-spinoff)
~385,000
2018; including Healthineers and Energy
Siemens Healthineers Employees
~66,000
At spinoff
Siemens Energy Employees
~92,000
At spinoff; including Gamesa
Siemens AG Revenue (post-spinoffs)
~€57B
FY2020; Digital, Infrastructure, Mobility
Revenue by Segment (FY2018)
Restructuring Overview
Siemens's breakup is a textbook example of European-style conglomerate restructuring — showing how a German industrial giant used carve-out IPO and spinoff methodologies to unlock conglomerate discount and create focused pure-play champions. This analysis examines both the methodology and the divergent post-separation outcomes.
Why Restructure
Conglomerate discount on German industrial complex + need to concentrate on digitalization
Siemens AG housed medical devices (high-growth, high-margin), energy (low-growth, cyclical), and industrial automation (moderate-growth) — businesses with fundamentally incompatible valuation logics. Combined in one entity, the high medical device multiples (P/E 30x+) were diluted by the energy business. Additionally, the Digital Industries (Industry 4.0) strategy required concentrated investment that a conglomerate structure could not prioritize efficiently.
Restructuring Methodology
Carve-Out IPOWhy This Method
For Healthineers, a carve-out IPO was appropriate to validate independent value in front of specialized medical device investors while Siemens retained majority ownership and growth participation. For Siemens Energy, a direct shareholder distribution spinoff enabled the energy business to pursue an independent energy cycle and wind growth strategy.
Alternatives Rejected
Cash Sale
Both Healthineers and Energy are closely tied to Germany's national industrial identity. A foreign sale would have generated significant political opposition.
Full Spinoff for Healthineers
A carve-out IPO allowed Siemens AG to retain 85% ownership and continue participating in healthcare growth, while validating independent value in public markets.
Maintain Single Integrated Entity
Continued multiple dilution across medical devices, energy, and automation would have prevented Siemens AG's digital transformation premium from being reflected in its valuation.
📚 Theoretical Framework
European Carve-out Strategy
Unlike the U.S. Section 355 tax-free spinoff structure, European practice more commonly favors partial IPOs (carve-outs) followed by gradual stake reduction. Differences in tax law and governance norms drive this preference.
Siemens retained an 85% stake in Healthineers at IPO and gradually reduced its holding based on market conditions — balancing immediate value crystallization with continued growth participation.
German Co-determination (Mitbestimmung) and Restructuring
German companies have worker representatives occupying half the supervisory board (Aufsichtsrat). Large-scale restructuring requires upfront union consultation and employment guarantees — slowing timelines but improving workforce outcomes.
The Siemens Energy spinoff required upfront negotiations with IG Metall and other unions, with employment guarantees agreed before the separation was finalized.
Energy Transition Risk
The shift to wind and solar power represents both a major opportunity and a significant technology maturity and supply chain risk. Siemens Gamesa's turbine quality problems illustrate the execution risks in energy transition capital deployment.
As an independent company, Siemens Energy absorbed billions in Gamesa turbine defect losses alone — without Siemens AG's balance sheet as a buffer. Siemens AG, in turn, was protected from those losses precisely because the spinoff had been completed.
📋 Execution Timeline
Siemens Healthineers Frankfurt Listing (SHL)
Siemens medical devices division listed via carve-out IPO on Frankfurt Stock Exchange. €4.2B raised. Siemens AG retained 85%. MRI, CT, ultrasound, diagnostics portfolio. Medical device multiples of 25x+ immediately applied.
Siemens Energy Spinoff Preparation + Gamesa Integration
Gas turbines, power transmission, and 67% Siemens Gamesa wind stake bundled into Siemens Energy AG. 35% shareholder distribution to Siemens AG shareholders approved.
Siemens Energy AG Frankfurt Spinoff Listing
Siemens Energy listed independently on Frankfurt Stock Exchange. 35% directly distributed to Siemens AG shareholders + DAX 30 inclusion. Initial market cap €16B. Siemens AG retained 35%.
Healthineers Acquires Varian + Siemens Energy Gamesa Crisis
Healthineers: Varian Medical (radiation therapy) $16B acquisition expands oncology capabilities. Energy: Siemens Gamesa turbine defects cause billions in losses; stock collapses; German government guarantee negotiations begin.
👥 Stakeholder Impact
Healthineers gains + Energy losses; net positive
Siemens Healthineers' market cap growth generated substantial returns for Siemens AG shareholders. Siemens Energy's stock decline offset some of those gains.
Independence + wind turbine crisis
Gamesa turbine defects made restructuring unavoidable post-independence. However, the surge in AI data center power demand improved the power grid and gas turbine outlook.
Benefited from focused medical device investment
Post-independence Varian acquisition and AI diagnostic software investment accelerated. Medical imaging AI is growing rapidly.
Focused national industrial champions created
Siemens's breakup produced focused German champions in each domain: Industry 4.0 automation (Siemens AG), medical devices (Healthineers), and energy transition (Siemens Energy) — each independently strengthening global competitiveness.
Intensified pure-play competition
Siemens Healthineers' independence sharpened direct competition with GE Healthcare and Philips in medical imaging and diagnostics.
📈 Market & Price Impact
Siemens stock +2% on Healthineers IPO announcement
Siemens AG stock +15% in the year following Energy spinoff
Siemens AG market cap €100B+ in 2024 (+80% vs. pre-breakup)
Healthineers success vs. Siemens Energy Gamesa crisis — sharply divergent outcomes by business unit illustrate the double-edged nature of spinoffs
Deal Structure
Siemens executed two separate methodologies for its two major spinoffs. Siemens Healthineers was listed via a carve-out IPO — Siemens AG retained 85% while floating 15% to public investors. Siemens Energy was distributed directly to Siemens AG shareholders via a full spinoff, with 35% allocated to existing shareholders. The choice of method for each reflected the specific nature of each business, German tax law considerations, and governance strategy.
Pre-Deal
Siemens AG
Frankfurt listed (SIE); German DAX
Siemens Energy Division
Gas turbines, power grids, Gamesa wind 67%
Siemens Gamesa Renewable Energy
Spanish-listed wind turbine manufacturer
Siemens Healthineers Division
Medical devices: MRI, CT, ultrasound, diagnostics
Post-Deal
Siemens AG
Digital, Infrastructure, Mobility focused; DAX
Siemens Energy AG (ENR)
Frankfurt listed; Siemens AG 35%
Siemens Healthineers (SHL)
Frankfurt listed; Siemens AG 75%+
Key Terms
Advisors
Major investment banks and law firms participated in each of Siemens's two spinoff transactions.
Restructuring Entity (Siemens AG) Advisors
Goldman Sachs
Financial Advisor (FA)Siemens Healthineers IPO bookrunner
JPMorgan
Financial Advisor (FA)Siemens Energy spinoff advisory
Linklaters
Legal CounselGerman and European spinoff structure
Freshfields Bruckhaus Deringer
Legal CounselListing regulations and governance
Spinoff Entities (Healthineers / Energy) Advisors
Deutsche Bank
Financial Advisor (FA)Healthineers IPO co-bookrunner
Morgan Stanley
Financial Advisor (FA)Healthineers global allocation bookrunner
Advisor information is based on public reporting.
Financials
Unit: EUR hundreds of millions (億). Siemens AG consolidated (including Healthineers and Energy) estimated figures.
| Item | FY2017 | FY2018 |
|---|---|---|
| Revenue | EUR 830億 | EUR 830億 |
| COGS | EUR 540億 | EUR 535億 |
| Gross Profit | EUR 290億 | EUR 295億 |
| SG&A | EUR 100億 | EUR 98億 |
| Operating Income | EUR 62億 | EUR 65億 |
| EBITDA | EUR 90億 | EUR 93億 |
| EBITDA Margin | 10.8% | 11.2% |
Valuation
The logic of Siemens's spinoffs was to unlock independent sector multiples that the conglomerate structure suppressed. Medical devices deserved a 25x EV/EBITDA premium multiple; energy a utility-like 8x. Together, they averaged down to a conglomerate multiple in the mid-teens — destroying value for both businesses.
| Metric | Value | Notes |
|---|---|---|
| Healthineers IPO Market Cap (2018) | €31B | Listing day |
| Healthineers EV/EBITDA | ~25x | Medical device premium multiple |
| Healthineers Market Cap (2023) | €33B+ | Reflects Varian acquisition and AI investment |
| Siemens Energy IPO Market Cap (2020) | €16B | Listing day |
| Siemens Energy EV/EBITDA | ~8x | Utility / energy sector multiple |
| Siemens Energy Market Cap (2023) | ~€12B (post-Gamesa crisis) | Turbine defects drove stock -50%+ |
| Siemens AG Market Cap (2024) | €100B+ | +80% vs. pre-breakup |
Market cap figures are estimates based on market data. EUR basis.
Share this deal
Deal Rationale
Restructuring Logic (Siemens AG — Why It Separated)
- Eliminating conglomerate discount — unlocking independent sector multiples for medical devices, energy, and automation
- Concentrating on digital industrial automation — dedicating R&D and capital to Industry 4.0, software, and digital twins
- Independent M&A freedom for each entity — Healthineers acquired Varian Medical; neither would have been possible inside the conglomerate
- Investor fit optimization — attracting healthcare investors, energy transition investors, and industrial automation investors separately
- Strengthening German industrial competitiveness — creating globally focused champions in each sector
Independent Logic for Each Spinoff Entity
- Siemens Healthineers — dedicated medical device company; direct access to healthcare investors and partners
- Siemens Energy — independently pursue the energy transition strategy (gas → renewables)
- Both entities — escape conglomerate capital allocation competition; design optimal independent capital structures
- Independent equity-based management incentives — compensation tied to each business's own performance
- Enhanced customer and partner trust — pure-play positioning without conflicts from unrelated businesses
Post-Deal Assessment (2024-12 as of)
Siemens Healthineers delivered on its independence thesis. In 2021, it acquired Varian Medical Systems — the world's leading radiation therapy company — for $16B, completing an oncology ecosystem from diagnosis to treatment. AI-powered medical imaging software investments accelerated. Market cap reached €33B+. Siemens Energy had a more turbulent journey. Shortly after fully acquiring Siemens Gamesa in 2022, quality defects in onshore wind turbines emerged — causing billions in losses, a stock crash of -50%+, and negotiations with the German government for state guarantees. However, a surge in AI data center power demand revived Siemens Energy's gas turbine and power grid businesses, driving a partial recovery in 2024.
Positives
- Siemens AG market cap €100B+ (2024) — +80% vs. pre-breakup
- Siemens Healthineers market cap €33B+ — medical device independent multiple unlocked
- Siemens AG Digital Industries P/E expansion from ~14x to ~20x+
- Healthineers Varian acquisition completed oncology ecosystem — major strategic expansion
- Siemens Energy gas turbines and power grids benefiting from AI data center power demand surge
Risks & Concerns
- Siemens Energy Gamesa wind turbine defects — billions in losses; stock -50%+
- Siemens Energy German government guarantee discussions — independent company's vulnerability exposed
- Siemens AG Healthineers stake reduction — diminishing participation in medical device growth
- Energy transition speed uncertainty — offshore wind cost inflation and supply chain challenges
- German economic slowdown and industrial automation demand softness — Siemens AG growth headwinds
This announcement appears as a matter of record only
Siemens AG
Acquirer
Siemens Healthineers / Siemens Energy
Target
German Industrial Empire Transformation
Transaction Size
Healthineers market cap €33B+
EUR 33B+ Healthineers market cap
EV / EBITDA
Healthineers ~25x | Energy ~8x
Multiple
Closed
Sep 2020
Deal Date
Editor's Note
Siemens's breakup provides a nuanced answer to the question 'is a spinoff always the right answer?' Healthineers thrived in independence — it could pursue the bold Varian acquisition without competing for capital inside a conglomerate. Siemens Energy faced its Gamesa crisis alone — inside Siemens AG, the parent's financial strength would have provided a buffer. The lesson: spinoffs eliminate the conglomerate discount while simultaneously removing the conglomerate's risk-absorbing function. Both effects are real — and the net outcome depends heavily on each business's standalone strength.
Key Concepts in This Deal
A separation method where the parent floats a minority stake in a subsidiary while retaining majority control
The phenomenon where a diversified company trades below the sum of its individual business valuations
Technology maturity and supply chain risks in the renewable energy transition — illustrated by the Siemens Gamesa case
Frequently Asked Questions
Why did Siemens use different methods for Healthineers vs. Energy?
The businesses had different strategic objectives. For Healthineers, Siemens wanted to unlock a medical device valuation multiple while retaining majority ownership and continuing to participate in its growth. A carve-out IPO — floating 15% while keeping 85% — achieved exactly that. For Energy, the goal was to give the energy business a fully independent capital structure suited to the energy transition cycle. A direct distribution to shareholders via spinoff severed the Siemens AG link more cleanly and aligned Energy with dedicated energy-sector investors.
Why did Siemens Healthineers acquire Varian Medical?
To complete the full oncology ecosystem — from cancer diagnosis to treatment. Varian Medical was the world's leader in medical linear accelerators (LINACs) and radiation therapy software. By adding Varian's treatment capabilities to Healthineers' diagnostic imaging (MRI, CT), the combined company could cover the full cancer care continuum: diagnosis → treatment → monitoring. Critically, Healthineers' independence made this bold $16B acquisition possible — as a business unit inside Siemens AG, competing for capital allocation would have been much harder.
What caused the Siemens Energy / Siemens Gamesa wind turbine crisis?
Shortly after Siemens Energy fully acquired Siemens Gamesa in 2022, quality defects emerged in Gamesa's onshore wind turbines — particularly in the rotor blades and internal components of the 5.X platform. The repair and replacement costs ran into billions of euros, new orders were paused, and write-downs mounted. As an independent company, Siemens Energy had to absorb the shock without the financial cushion of Siemens AG. It ultimately had to negotiate German government guarantees. The episode illustrates the technology maturity and supply chain risks embedded in energy transition investments.
Was the Siemens breakup ultimately a success?
On balance, yes — but the results diverged sharply by business. Siemens AG's own market cap rose +80% post-breakup to €100B+. Healthineers is unambiguously successful, reaching €33B+ and executing the transformative Varian acquisition. Siemens Energy is the cautionary tale — the Gamesa crisis caused a -50%+ stock decline and required government support. The core lesson: spinoffs eliminate the conglomerate discount while simultaneously removing the conglomerate's ability to absorb subsidiary losses. The net outcome depends heavily on each business's standalone resilience.
Was this helpful?
Share it with someone
Related Deals
Sources & Notes
- [1]Siemens AG Press Release — Siemens Healthineers IPO Prospectus (March 2018)
- [2]Siemens AG Press Release — Siemens Energy Spin-off (September 2020)
- [3]Siemens AG Annual Report FY2020 — Vision 2020+ Strategy Update
- [4]Frankfurt Stock Exchange — Siemens Healthineers (SHL) IPO Filing (2018)
- [5]The Wall Street Journal — Siemens Spins Off Its Energy Unit (September 2020)
- [6]Financial Times — Siemens Energy Faces Crisis Over Gamesa Wind Turbine Defects (2023)
- [7]Bloomberg — Siemens Healthineers Acquires Varian Medical for $16.4 Billion (2021)
- [8]Handelsblatt — Siemens Vision 2020+ Strategy and Consequences (2019)